Global Prefilled Syringes Market Estimated to Cross US $11 Bn by End of the Year of Assessment (2026)
Success of biologic drugs, owing to their capability to treat chronic diseases, has taken the pharmaceutical industry to a new level. Biologics, offering enhanced curing abilities without side effects are being widely used to treat chronic ailments such as cancer and other autoimmune diseases. With FDA approval, several companies have been introducing novel biologic drugs for various therapeutic areas. This has made delivery of biologics an important aspect.
View full press release